Hervycta Plus 150mg Injection: Effective Solution for Your Needs

Hervycta Plus 150mg Injection

Uses:

• Advanced and metastatic breast cancer.
• Metastatic gastric cancer with increased levels of HER2 proteins.

Therapeutic Effects:

• Selectively binds to HER2 proteins, stopping the growth of cancer cells.

Important Information:

• Not recommended for patients under 18, those with severe breathing problems, or those needing oxygen treatment.
• Inform your physician about any heart problems, breathlessness, or previous cancer treatment.
• Discuss all medications, including supplements and herbal medicines, with your physician before starting treatment.

Storage:

• Keep out of sight and reach of children.
• Store between 2°C and 8°C.

Administration:

• Administered before or after surgery.
• Given as an intravenous infusion for 90 minutes; if well tolerated, administered within 30 minutes for subsequent doses.

Safety Advice:

• Pregnancy: Discuss with your physician before taking if pregnant or planning to become pregnant.
• Breastfeeding: Avoid breastfeeding while on treatment and for at least seven months after the final dose.
• Lungs: Consult your doctor if you have any lung conditions before starting treatment.
• Liver: Inform your physician if you have any liver disorders for dosage adjustment.
• Alcohol: Consult your doctor about alcohol consumption during treatment.
• Driving: Avoid driving or handling machinery due to potential side effects like tiredness and dizziness.

Side Effects:

• Serious: Heart problems, allergic reactions, kidney problems, breathing difficulties.
• Common: Fever, visual disturbances, nose bleeds or runny nose, hair loss, dizziness, nail disorders, weight loss, loss of appetite, bruising, dry mouth, liver inflammation, muscle pain, asthma/lung disorders.

FAQ:

• Q1: Is Hervycta Plus 150mg Injection used as a monotherapy in treating breast cancer?
  • A: Generally given along with chemotherapy medications such as paclitaxel or docetaxel or platinum compounds. Sometimes given with hormonal agents for patients with elevated hormonal status.
• Q2: Does Hervycta Plus 150mg Injection cause heart problems?
  • A: Yes, can damage heart muscles. Heart check-ups recommended every 3 months and continued for 2-5 years after treatment completion.
• Q3: Can I breastfeed while on treatment with Hervycta Plus 150mg Injection?
  • A: No, it is unsafe to breastfeed. Avoid breastfeeding for at least 7 months after treatment.
• Q4: Can Hervycta Plus 150mg Injection be consumed during pregnancy?
  • A: No, it can cause harm to the baby. Discuss birth control methods with your physician.

Fact Box:

• Molecule name: Trastuzumab.
• Therapeutic class: Anti-cancer.
• Pharmacological class: HER2 inhibitor.
• Indications:
  • Advanced and metastatic breast cancer.
  • Metastatic gastric cancer.

Tags: medical-injection, hervycta-plus, pain-relief, anti-inflammatory, 150mg